NCT07189130

Brief Summary

The aim of this study is to investigate different resistance training loads on BNDF and irisin levels in platelets, blood serum and plasma.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started May 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
May 2025Sep 2026

Study Start

First participant enrolled

May 12, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 23, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

August 19, 2025

Last Update Submit

December 15, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • plasma BDNF

    BDNF will be determined in blood plasma with ELISA kit.

    pre, 5 minutes post exercise, 1 hour post exercise, 3 hours post exercise.

  • Irisin

    Irisin will be measured in blood plasma.

    pre, 5 minutes post exercise, 1 hour post exercise, 3 hours post exercise.

  • serum BDNF

    BDNF will be determined in blood serum with ELISA kit.

    pre, 5 minutes post exercise, 1 hour post exercise, 3 hours post exercise.

  • Platelet count

    Platelet count in blood will be done.

    pre, 5 minutes post exercise, 1 hour post exercise, 3 hours post exercise.

  • BDNF per platelet

    The amount of BDNF per platelet will be calculated.

    pre, 5 minutes post exercise, 1 hour post exercise, 3 hours post exercise.

Secondary Outcomes (2)

  • Lactate

    pre, 5 minutes post exercise, 1 hour post exercise, 3 hours post exercise.

  • Stroop test

    pre, 15 minutes post exercise.

Study Arms (1)

Intervention: participants going through exercising or control

EXPERIMENTAL

All participants will do 1 control protocol and 3 resistance exercises protocols. Order of protocols will be randomized.

Other: Exercise: 80% 1 RM with 2 minutes breakOther: Exercise: 80% 1RM with1 minute breakOther: Exercise: accenuated eccentric exerciseOther: Control

Interventions

Participant will do resistance exercise at 80% 1RM with 2 minutes break, 4 sets of each exercise. Included exercises are lat pull, bench press and leg press.

Also known as: resistance exercise
Intervention: participants going through exercising or control

Participant will do resistance exercise at 80% 1RM with 1 minutes break, 4 sets of each exercise. Included exercises are lat pull, bench press and leg press.

Also known as: resistance exercise
Intervention: participants going through exercising or control

Participant will do accenuated eccentric resistance exercise at 80% 1RM in concetric part of movement and 110% 1RM in eccentric part of movement with 2 minutes break, 4 sets of each exercise. Included exercises are lat pull, bench press and leg press.

Intervention: participants going through exercising or control
ControlOTHER

Timeline of events will be same as in exercise protocol (blood withdrawal and Stroop test), except participants will not do any kind of exercise protocol, instead they will be seating.

Intervention: participants going through exercising or control

Eligibility Criteria

Age18 Years - 30 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsBiological males.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • males between 18 and 30 years
  • moderate level of physical activity assessed with IPAQ

You may not qualify if:

  • injuries
  • cardiovascular diseases
  • respiratory diseases
  • psychiatric diseases
  • metabolic diseases
  • other neurodegenerative diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ljubljana, Faculty of Sport

Ljubljana, 1000, Slovenia

Location

MeSH Terms

Interventions

ExerciseResistance Training

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, Human

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2025

First Posted

September 23, 2025

Study Start

May 12, 2025

Primary Completion

November 25, 2025

Study Completion (Estimated)

September 1, 2026

Last Updated

December 16, 2025

Record last verified: 2025-12

Locations